Strategic Partnerships Curant Health has a history of forming targeted partnerships with health plans and specialty providers (Security Health, Corcept Therapeutics, IWILFIN program via Curant Rare). This indicates sales opportunities around reinforced collaboration agreements, payer-facing care management programs, and exclusive pharmacy partnerships that enhance therapy access and outcomes.

Rare and Orphan Focus The launch of Curant Rare and the exclusive pharmacy partnership for IWILFIN highlight a strategic emphasis on rare and orphan diseases. This creates a growth vector for selling specialized services, care coordination, and patient support programs tailored to high-need, low-volume therapies.

Outcomes Driven With a clear emphasis on outcomes-based patient support and pharmacist-managed medication management, there is a strong value proposition for payers and providers seeking to reduce hospital utilization and total cost of care through improved adherence and monitoring.

Data and Analytics Existing tech stack includes SAS, Azure DevOps, Qualtrics, and data-oriented collaboration with health plans. This supports selling analytics-driven care management, predictive insights, and longitudinal engagement for chronic conditions such as heart failure.

Expansion Readiness Recent press and program launches indicate readiness to scale through new markets and programs. This suggests opportunities to present scalable solutions that align with growth in rural and underserved populations, as well as opportunities to align with large health systems expanding specialty pharmacy services.